ARID1A and breast carcinoma: To experimentally prove an inverse correlation in predicted target pairs, miR-129-5p and miR-3613-3p were ectopically expressed in cell lines of different cancer types, including SNU-1 (gastric cancer), HCT116 (colon cancer), MCF-7 and SKBR3 (breast cancer), 769-P (renal cell carcinoma) and A549 (lung cancer) followed by quantification of ARID1A expression.